The Global Sustained Release Excipients Industry is on the cusp of a significant expansion, driven by the increasing demand for long-acting medications. According to a recent industry analysis, the market is currently valued at a staggering US$1,198.69 million in 2022 and is forecast to surge at a remarkable Compound Annual Growth Rate (CAGR) of 7.5%. …
Tag Archives: Global Sustained Release Excipients Industry
Global Sustained Release Excipients Industry Poised for Unprecedented 6.8% CAGR Surge through 2026 | Predicts FMI
The Global Sustained Release Excipients Industry is on the brink of an unprecedented era of expansion, poised for a remarkable Compound Annual Growth Rate (CAGR) of 6.8% that is expected to reshape market dynamics through 2026. This projected growth signals a pivotal departure from historical trends characterized by regional competition and pricing strategies. Traditionally, the …
Global Sustained Release Excipients Industry Anticipates Unprecedented 6.8% CAGR Growth through 2026 | FMI
The Global Sustained Release Excipients Industry is poised for a remarkable expansion, with a projected Compound Annual Growth Rate (CAGR) of 6.8% expected to drive significant market demand through 2026. This growth represents a pivotal moment for the industry, marking a departure from historical trends characterized by regional competition and pricing strategies. Traditionally, the Global …
Global Sustained Release Excipients Industry Set to Achieve 6.8% CAGR Growth by 2026 | FMI’s Insight
In the dynamic landscape of the Sustained Release Excipients Industry, local manufacturers have traditionally held sway through competitive pricing strategies. This has resulted in a fragmented market, challenging the profitability of businesses. However, a significant shift is underway, driven by increasing awareness of sustained release excipients and concerns regarding test specificity and sensitivity in locally …